Association of Pre-ESRD Serum Calcium With Post-ESRD Mortality Among Incident ESRD Patients: A Cohort Study.

作者: Yoshitsugu Obi , Christina Park , Melissa Soohoo , Keiichi Sumida , Takayuki Hamano

DOI: 10.1002/JBMR.3391

关键词:

摘要: Albumin-corrected serum calcium (cSCa) decline at late stages of chronic kidney disease and rise after dialysis initiation. Although hypercalcemia is associated with higher mortality in end-stage renal (ESRD), there are scarce data on the impact pre-ESRD cSCa post-ESRD mortality. Therefore, we used a large national cohort 21,826 US veterans who transitioned to all Department Veterans Affairs health care facilities over 2009 2014 examine associations all-cause cause-specific (1) concentrations averaged last 6 months (2) its rate during 12 before Mean median were 9.3 ± 0.7 mg/dL -0.15 (interquartile range -0.39 0.07) mg/dL/year, respectively. A total 9596 patients died follow-up period (mean 1.9 years; 41,541 patient-years) an incidence 23.1 per 100 patient-years. There was independent linear association between (ptrend < 0.001). The risk ≥9.0 mg/dL attenuated among active vitamin D users (pinteraction Patients faster showed lower irrespective baseline concentrations. These cSCa-mortality stronger for noncardiovascular versus cardiovascular death. In conclusion, consistently linearly better survival veterans, especially Further studies needed determine if correcting hypocalcemia beneficial or harmful which intervention preferred when indicated transitioning ESRD. © 2018 American Society Bone Mineral Research.

参考文章(55)
M.L. Melamed, J.A. Eustace, L. Plantinga, B.G. Jaar, N.E. Fink, J. Coresh, M.J. Klag, N.R. Powe, Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study Kidney International. ,vol. 70, pp. 351- 357 ,(2006) , 10.1038/SJ.KI.5001542
Geoffrey A. Block, David M. Spiegel, James Ehrlich, Ravindra Mehta, Jill Lindbergh, Albert Dreisbach, Paolo Raggi, Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis Kidney International. ,vol. 68, pp. 1815- 1824 ,(2005) , 10.1111/J.1523-1755.2005.00600.X
Thomas B. Connor, Barry L. Rosen, Mordecai P. Blaustein, Mark M. Applefeld, L. Austin Doyle, Hypocalcemia Precipitating Congestive Heart Failure The New England Journal of Medicine. ,vol. 307, pp. 869- 872 ,(1982) , 10.1056/NEJM198209303071407
Yoshitsugu Obi, Takayuki Hamano, Naotsugu Ichimaru, Kodo Tomida, Isao Matsui, Naohiko Fujii, Masayoshi Okumi, Jun-ya Kaimori, Koji Yazawa, Yukito Kokado, Norio Nonomura, Hiromi Rakugi, Shiro Takahara, Yoshitaka Isaka, Yoshiharu Tsubakihara, Vitamin D Deficiency Predicts Decline in Kidney Allograft Function: A Prospective Cohort Study The Journal of Clinical Endocrinology and Metabolism. ,vol. 99, pp. 527- 535 ,(2014) , 10.1210/JC.2013-2421
Takayuki Hamano, Chikako Nakano, Yoshitsugu Obi, Naohiko Fujii, Isao Matsui, Kodo Tomida, Satoshi Mikami, Kazunori Inoue, Akihiro Shimomura, Yasuo Kusunoki, Hiromi Rakugi, Yoshitaka Isaka, Yoshiharu Tsubakihara, Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline Kidney International. ,vol. 3, pp. 469- 475 ,(2013) , 10.1038/KISUP.2013.97
Yoshitsugu Obi, Hemn Qader, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Latest consensus and update on protein-energy wasting in chronic kidney disease. Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 18, pp. 254- 262 ,(2015) , 10.1097/MCO.0000000000000171
Csaba P Kovesdy, Shahram Ahmadzadeh, John E Anderson, Kamyar Kalantar-Zadeh, Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease JAMA Internal Medicine. ,vol. 168, pp. 397- 403 ,(2008) , 10.1001/ARCHINTERNMED.2007.110
A. Levin, G.L. Bakris, M. Molitch, M. Smulders, J. Tian, L.A. Williams, D.L. Andress, Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney International. ,vol. 71, pp. 31- 38 ,(2007) , 10.1038/SJ.KI.5002009
Yoshitsugu Obi, Naotsugu Ichimaru, Takayuki Hamano, Kodo Tomida, Isao Matsui, Naohiko Fujii, Masayoshi Okumi, Jun-ya Kaimori, Koji Yazawa, Yukito Kokado, Yoshiharu Tsubakihara, Norio Nonomura, Hiromi Rakugi, Shiro Takahara, Yoshitaka Isaka, Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy Cancer Prevention Research. ,vol. 5, pp. 1229- 1235 ,(2012) , 10.1158/1940-6207.CAPR-12-0218